Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Kim YJ, Zhu Y, Ma F, Yu J, Wang YC, Chen X, Li Z, Zeng S, Wang X, Lee D, Ku J, Tsao T, Hardoy C, Huang J, Cheng D, Montel-Hagen A, Seet CS, Crooks GM, Larson SM, Sasine JP, Wang X, Pellegrini M, Ribas A, Kohn DB, Witte O, Wang P, Yang L.
Li YR, et al. Among authors: yang l.
Cell Rep Med. 2021 Nov 16;2(11):100449. doi: 10.1016/j.xcrm.2021.100449. eCollection 2021 Nov 16.
Cell Rep Med. 2021.
PMID: 34841295
Free PMC article.